Suchergebnisse - "Cooper, Lucy"

PubPharm (58)

1

Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection

enthalten in: Immunity | 2024

von Cooper, L. | Xu, H. | Polmear, J. | +19

2

Type I interferon dynamics determines memory B cell epigenetic identity in chronic viral infection

enthalten in: bioRxiv.org | 2023

von Cooper, L. | Xu, H. | Polmear, J. | +13

3

Elevated BMI reduces the humoral response to SARS-CoV-2 infection

enthalten in: Clinical & translational immunology | 2023

von Tong, M. | Sng, J. | Carney, M. | +20

4

Enhancing the health of NHS staff : eTHOS - protocol for a randomised controlled pilot trial of an employee health screening clinic for NHS staff to reduce absenteeism and presenteeism, compared with usual care

enthalten in: Pilot and feasibility studies | 2022

von Adams, R. | Jordan, R. | Adab, P. | +17

5

Enhancing the health of NHS staff: eTHOS — protocol for a randomised controlled pilot trial of an employee health screening clinic for NHS staff to reduce absenteeism and presenteeism, compared with usual care

enthalten in: Pilot and feasibility studies | 2022

von Adams, R. | Jordan, R. | Adab, P. | +17

6

Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection

enthalten in: Nature immunology | 2022

von Di Pietro, A. | Polmear, J. | Cooper, L. | +15

7

COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals

enthalten in: bioRxiv.org | 2022

von Nguyen, A. | Szeto, C. | Chatzileontiadou, D. | +19

8

Addressing smoking in sheltered homelessness with intensive smoking treatment (ASSIST project) : A pilot feasibility study of varenicline, combination nicotine replacement therapy and motivational interviewing

enthalten in: Addictive behaviors | 2022

von Skelton, E. | Lum, A. | Cooper, L. | +9

9

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 : A Placebo-Controlled Randomized Clinical Trial

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2021

von Frishberg, Y. | Deschênes, G. | Groothoff, J. | +70

CommentIn: Int J Surg. 2023 Feb 01;109(2):83-84. - PMID 36799810

10

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

enthalten in: The New England journal of medicine | 2021

von Garrelfs, S. | Frishberg, Y. | Hulton, S. | +90

CommentIn: Kidney Int. 2022 Feb;101(2):208-211. - PMID 34102220

1
2
3
4
5
6
Nächster »
[6]